GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » Gross Profit

Plandai Biotechnology (Plandai Biotechnology) Gross Profit : $0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology Gross Profit?

Plandai Biotechnology's gross profit for the six months ended in Jun. 2023 was $0.00 Mil. Plandai Biotechnology's gross profit for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Plandai Biotechnology's gross profit for the six months ended in Jun. 2023 was $0.00 Mil. Plandai Biotechnology's Revenue for the six months ended in Jun. 2023 was $0.00 Mil. Therefore, Plandai Biotechnology's Gross Margin % for the quarter that ended in Jun. 2023 was N/A%.

Plandai Biotechnology had a gross margin of N/A% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of Plandai Biotechnology was 26.39%. The lowest was -745.16%. And the median was -168.25%.


Plandai Biotechnology Gross Profit Historical Data

The historical data trend for Plandai Biotechnology's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology Gross Profit Chart

Plandai Biotechnology Annual Data
Trend Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.63 -0.69 -0.65 - -

Plandai Biotechnology Semi-Annual Data
Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.63 -0.69 -0.65 - -

Competitive Comparison of Plandai Biotechnology's Gross Profit

For the Shell Companies subindustry, Plandai Biotechnology's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Plandai Biotechnology's Gross Profit Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Plandai Biotechnology's Gross Profit distribution charts can be found below:

* The bar in red indicates where Plandai Biotechnology's Gross Profit falls into.



Plandai Biotechnology Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Plandai Biotechnology's Gross Profit for the fiscal year that ended in Jun. 2023 is calculated as

Gross Profit (A: Jun. 2023 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Plandai Biotechnology's Gross Profit for the quarter that ended in Jun. 2023 is calculated as

Gross Profit (Q: Jun. 2023 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Gross Profit for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Plandai Biotechnology's Gross Margin % for the quarter that ended in Jun. 2023 is calculated as

Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Plandai Biotechnology  (OTCPK:PLPL) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Plandai Biotechnology had a gross margin of N/A% for the quarter that ended in Jun. 2023 => No sustainable competitive advantage


Plandai Biotechnology Gross Profit Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Plandai Biotechnology (Plandai Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
4811 49th Street, San Diego, CA, USA, 92115
Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.
Executives
Callum Baylis-duffield director FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula other: Former Director 175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson director P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield director, officer: President, Secretary and CFO 2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield director 2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki director 21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866